Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6519511 | 0.94 | DGKA (0.34) | DGKALMNAL3MBTL1EPHX2FNTA | |
| SCHEMBL6514927 | 0.92 | DGKA (0.33) | DGKALMNAL3MBTL1EPHX2KDM4E | |
| SCHEMBL6519650 | 0.91 | TOP2A (0.36) | DGKALMNAL3MBTL1TOP2AFNTA | |
| SCHEMBL6519439 | 0.86 | DGKA (0.39) | DGKALMNAL3MBTL1EPHX2FNTA | |
| SCHEMBL6513764 | 0.85 | TDP1 (0.48) | LMNAL3MBTL1HDAC3KDM4E | |
| SCHEMBL6514996 | 0.84 | ALDH1A1 (0.41) | DGKAEPHX2FNTAFNTB | |
| SCHEMBL6515070 | 0.84 | DGKA (0.39) | DGKAL3MBTL1EPHX2 | |
| SCHEMBL6516722 | 0.82 | HCAR2 (0.36) | DGKALMNATOP2AFNTAFNTB | |
| SCHEMBL6513357 | 0.82 | ALDH1A1 (0.33) | DGKATOP2AFNTAFNTB | |
| SCHEMBL6515183 | 0.81 | DGKA (0.38) | DGKALMNAL3MBTL1EPHX2TOP2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | DGKA 3006/4885LMNA 2459/4885L3MBTL1 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.